The Indian pharmaceutical sector was valued at over USD 50 billion in FY 2023-24 and is expected to reach USD 130 billion by 2030. Within this landscape, the contract research and production (CRAMS) sector, which includes injection third-party manufacturing services, is expected to grow rapidly. According to a Boston Consulting Group report, the CRDMO (Contract Research, Development, and Manufacturing Organization) market might grow roughly sevenfold to USD 22-25 billion by the end of 2035, driven by global supply chain diversification.
In terms of the market size and growth dynamics of this industry, pharmaceutical injectables are a rapidly growing segment. The generic injectables market in India was valued at USD 2.7 billion in 2023 and is predicted to increase at a change of 10.8% from 2024 to 2032. Overall pharmaceutical production, including injectables, is expected to reach USD 17.79 billion in 2023, with a change of 10.5% through 2030.
In addition, the injection third-party manufacturing businesses in India is gaining traction, supported by market expansion, cost advantages, regulatory compliance, global demand shifts, government backing, and enhanced skills in specialized formulations. Thus, this business has a scalable and high-growth approach that is increasingly appealing to both domestic and foreign pharmaceutical companies.
Injection manufacturing is one of the most sensitive and regulated operations in the pharmaceutical industry since injections are administered directly into the bloodstream or tissues. Therefore, precision, sterility, and compliance are crucial. Being a reputed injection manufacturing plant, we have given a clear and expert description of the main steps of the injection third-party manufacturing services:
In the beginning, Smayan Injectables used therapeutic methods for the selection of active pharmaceutical ingredients (APIs). Then, we do some compatibility tests with solvents, stabilisers, and excipients. Also, we design the appropriate dose form (liquid, dry powder, lyophilised, or pre-filled syringes).
We ensure APIs and excipients are acquired from certified, GMP-approved sources. Therefore, our raw materials are tested for purity, potency, and the absence of impurities.
Our production team ensured that APIs is always accurately weighed and dissolved in a sterile solvent. Following that, we mixed with stabilisers, buffers, and preservatives as needed. Also, we maintain pH, osmolarity, and isotonicity according to product specifications.
To eliminate germs and particles, the solution passed through sterilising filters with 0.22-micron pores. As an US FDA approved injectable plant in India, we ensure that the fluid is clear and sterile.
We make sure that under aseptic conditions, the solution loaded into ampoules, vials, or prefilled syringes. After this, when sealing is done in sterile locations, we protect our ready products free from contamination.
In this time, lyophilizers freeze the solution and remove the water through sublimation. Also, in our injection manufacturing plant, we create stable dry powder injections for reconstitution.
Our company ensures that some injections are autoclaved at high pressures and temperatures. We ensure sterility in all of our products without compromising the active substances.
With the help of our quality check team, we make sure that each batch checked for:
Sterility Tests (no microbial growth)
Particulate Matter Test
Assay (Potency Test)
pH and Stability Checks
Also, all of our documentation should adhere to WHO-GMP and DCGI guidelines.
Now, we come to the packaging, and we do labelled sterile packing in ampoules, vials, or syringes. In our secondary packaging in cartons, including inserts (dosage, storage, and usage directions).
Most importantly, we always store injectables and other items in temperature-controlled warehouses (2-8°C for cold chain items). Then, we dispatch them with approved logistics to assure stability till consumption.
Our organization has long been a leading US FDA approved injectable plant in India. Various injectables and medicines businesses or clients who come to our company always profit from our lower labour and operating costs. They do not need to invest a lot of money in their companies’ production departments. Even with this, by utilising our services, healthcare organizations may freely focus on their key competencies, such as research, development, and marketing, rather than manufacturing logistics.
Instead of focusing on industrial procedures, they also allocate their resources to better-directed innovation. Furthermore, our entire team of injection manufacturing plant specializes in producing specific healthcare items that consistently deliver high-quality results. In addition, we have complete access to cutting-edge production technologies and machines that improve our product quality and efficiency significantly.
Apart from this, our organization is constantly committed to ongoing progress and innovation. This ensures that our customers always receive fresh, higher-quality products. As a result, we hope you now realize how injection third-party manufacturing services to specialists might benefit your pharmaceutical firm. So, if you want to deal with the genuine and certified injection manufacturer in India, contact only Smayan Injectables.
List of Injectables by Smayan Injectables
Hormonal Injections
Anti Allergic Injections
Iron Sucrose Injections
Vasopressin Injections
Tranexamic Acid Injections
Ranitidine Injections
Ondansetron Injections
Labetalol Injections
Methylcobalamin Injections
Thiocolchicoside Injections
At the essence, Smayan Injectables is the right choice if you want to invest in a trusted injection third-party manufacturing services in India. Related to every demand for the injectable range, we may fulfill for you. Thus, you can easily get our manufacturing services at the best prices.